117 related articles for article (PubMed ID: 9677642)
1. [Eruption after the 1st dose of standard antitubercular chemotherapy. Thoughts on pyrazinamide].
Radal M; Jonville-Bera AP; Van-Egroo C; Carré P; Lemarié E; Autret E
Rev Mal Respir; 1998 Jun; 15(3):305-6. PubMed ID: 9677642
[TBL] [Abstract][Full Text] [Related]
2. [-Skin eruption after the first dose of antitubercular quadri-therapy: consideration of pyrazinamide-].
Olivier C; Radal M; Mazaud S; Jonville-Béra AP; Martel C; Autret E
Arch Pediatr; 1998 Mar; 5(3):289-90. PubMed ID: 10327997
[TBL] [Abstract][Full Text] [Related]
3. [Cutaneous reaction after pyrazinamide initiation].
Mulliez P; Mbassi Fouda FL; Roy Saint-Georges F
Med Mal Infect; 2011 Sep; 41(9):499-500. PubMed ID: 21458177
[No Abstract] [Full Text] [Related]
4. A 32-year-old man with tuberculosis, fever, and rash.
Story RE; Ditto AM
Ann Allergy Asthma Immunol; 2004 May; 92(5):495-9. PubMed ID: 15191016
[No Abstract] [Full Text] [Related]
5. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
6. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
[TBL] [Abstract][Full Text] [Related]
7. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis.
Yee D; Valiquette C; Pelletier M; Parisien I; Rocher I; Menzies D
Am J Respir Crit Care Med; 2003 Jun; 167(11):1472-7. PubMed ID: 12569078
[TBL] [Abstract][Full Text] [Related]
8. [Liver injury under tuberculostatic treatment].
Fattinger K; Braunschweig S; Reichen J; Meier-Abt PJ; Krähenbühl S
Praxis (Bern 1994); 1997 Apr; 86(15):626-9. PubMed ID: 9213916
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic approach in a case of allergic reaction to antituberculosis drugs -- a case report].
Costin M; Tesloianu A; Mihăescu T; Butnaru E
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):487-9. PubMed ID: 23077942
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis.
Schaberg T; Rebhan K; Lode H
Eur Respir J; 1996 Oct; 9(10):2026-30. PubMed ID: 8902462
[TBL] [Abstract][Full Text] [Related]
11. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
12. [Fixed drug eruption after taking ethambutol].
Bakayoko AS; Kaloga M; Kamagate M; Kone Z; Daix AT; Ohui E; Gbery I; Domoua K
Rev Mal Respir; 2015 Jan; 32(1):48-51. PubMed ID: 25618204
[TBL] [Abstract][Full Text] [Related]
13. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
Ahn HC; Lee YC
Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
[TBL] [Abstract][Full Text] [Related]
14. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV
Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879
[TBL] [Abstract][Full Text] [Related]
15. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
Teo SK
Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
17. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koula-Shiro S
Cent Afr J Med; 1998 Feb; 44(2):34-7. PubMed ID: 9675969
[TBL] [Abstract][Full Text] [Related]
18. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W
Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263
[TBL] [Abstract][Full Text] [Related]
19. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
Su WJ; Perng RP
Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151
[TBL] [Abstract][Full Text] [Related]
20. [Antitubercular chemotherapy].
Jouveshomme S; Dautzenberg B
Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
